Literature DB >> 35536017

Vaccine uptake and barriers to vaccination among at-risk adult populations in the US.

Irina Kolobova1, Mawuli Kwame Nyaku1, Anna Karakusevic2, Daisy Bridge2, Iain Fotheringham2, Megan O'Brien1.   

Abstract

To reduce morbidity and mortality associated with vaccine-preventable diseases (VPD), it is imperative that vaccination programs are implemented and prioritized throughout all stages of life across all populations. This study aimed to determine vaccine uptake and barriers to vaccination against VPDs among at-risk adult populations in the United States. We conducted a systematic literature review for articles published between January 2010 and June 2020 and identified 153 publications. The review identified 17 at-risk populations. Vaccine uptake was suboptimal among many populations, with factors including age, gender, and disease severity, associated with uptake. This review identified several barriers that impact vaccine uptake among at-risk populations, with concerns over safety, vaccine costs, lack of insurance, and lack of provider recommendation commonly reported across populations. Embracing a national life-course immunization framework that integrates developing policies, guidelines, and education would be a step to addressing these barriers.

Entities:  

Keywords:  Vaccine-preventable diseases; at-risk population; barriers; life-course immunization; population health; public health; vaccine uptake rate

Mesh:

Substances:

Year:  2022        PMID: 35536017      PMCID: PMC9248946          DOI: 10.1080/21645515.2022.2055422

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   4.526


  107 in total

1.  Protecting the public's health: critical functions of the Section 317 Immunization Program-a report of the National Vaccine Advisory Committee.

Authors: 
Journal:  Public Health Rep       Date:  2013 Mar-Apr       Impact factor: 2.792

2.  HPV and HPV vaccine education intervention: effects on parents, healthcare staff, and school staff.

Authors:  Paul L Reiter; Brenda Stubbs; Catherine A Panozzo; Dianne Whitesell; Noel T Brewer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-09-23       Impact factor: 4.254

3.  Mortality of dialysis patients according to influenza and pneumococcal vaccination status.

Authors:  T Christopher Bond; Anne C Spaulding; Jenna Krisher; William McClellan
Journal:  Am J Kidney Dis       Date:  2012-06-12       Impact factor: 8.860

4.  Life-course immunization as a gateway to health.

Authors:  Roy K Philip; Katie Attwell; Thomas Breuer; Alberta Di Pasquale; Pier Luigi Lopalco
Journal:  Expert Rev Vaccines       Date:  2018-10       Impact factor: 5.217

5.  Disclosure of Sexual Orientation and Uptake of HIV Testing and Hepatitis Vaccination for Rural Men Who Have Sex With Men.

Authors:  Nicholas Metheny; Rob Stephenson
Journal:  Ann Fam Med       Date:  2016-03       Impact factor: 5.166

6.  Cost-Effectiveness of Meningococcal Vaccination Among Men Who Have Sex With Men in New York City.

Authors:  Matthew S Simon; Don Weiss; Anita Geevarughese; Molly M Kratz; Blayne Cutler; Roy M Gulick; Jane R Zucker; Jay K Varma; Bruce R Schackman
Journal:  J Acquir Immune Defic Syndr       Date:  2016-02-01       Impact factor: 3.731

7.  Susceptibility to Hepatitis A Virus Infection in the United States, 2007-2016.

Authors:  Shaoman Yin; Laurie Barker; Kathleen N Ly; Greta Kilmer; Monique A Foster; Jan Drobeniuc; Ruth B Jiles
Journal:  Clin Infect Dis       Date:  2020-12-17       Impact factor: 9.079

8.  Improving outcomes for diverse populations disproportionately affected by diabetes: final results of Project IMPACT: Diabetes.

Authors:  Benjamin M Bluml; Lindsay L Watson; Jann B Skelton; Patti Gasdek Manolakis; Kelly A Brock
Journal:  J Am Pharm Assoc (2003)       Date:  2014 Sep-Oct

9.  Cost-effectiveness of administering 13-valent pneumococcal conjugate vaccine in addition to 23-valent pneumococcal polysaccharide vaccine to adults with immunocompromising conditions.

Authors:  Bo-Hyun Cho; Charles Stoecker; Ruth Link-Gelles; Matthew R Moore
Journal:  Vaccine       Date:  2013-10-19       Impact factor: 3.641

10.  Influenza vaccination coverage among health care personnel--United States, 2013-14 influenza season.

Authors:  Carla L Black; Xin Yue; Sarah W Ball; Sara M A Donahue; David Izrael; Marie A de Perio; A Scott Laney; Megan C Lindley; Samuel B Graitcer; Peng-Jun Lu; Walter W Williams; Carolyn B Bridges; Charles DiSogra; John Sokolowski; Deborah K Walker; Stacie M Greby
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-09-19       Impact factor: 17.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.